Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 2/20 | 0.46 |
| ▸ | GNB1 | P62873 | 2/20 | 0.46 |
| ▸ | AKT1 | P31749 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | APP | P05067 | 2/20 | 0.39 |
| ▸ | SNCA | P37840 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31536705 | 0.98 | GNG2 (0.45) | GNG2GNB1AKT1MAPTAPP | |
| SCHEMBL4074621 | 0.95 | GNG2 (0.49) | GNG2GNB1AKT1MAPTAPP | |
| Sulfuric Acid SCHEMBL944027 | 0.92 | GNG2 (0.40) | GNG2GNB1AKT1MAPTAPP | |
| SCHEMBL13320814 | 0.88 | ALDH1A1 (0.44) | GNG2GNB1AKT1MAPTAPP | |
| SCHEMBL13891631 | 0.87 | GNG2 (0.43) | GNG2GNB1AKT1MAPTAPP | |
| SCHEMBL10048542 | 0.83 | APAF1 (0.41) | GNG2GNB1AKT1MAPTAPP | |
| Sulfuric Acid SCHEMBL4920843 | 0.81 | ALDH1A1 (0.39) | GNG2GNB1AKT1MAPTAPP | |
| Sulfuric Acid SCHEMBL31536708 | 0.81 | GNG2 (0.38) | GNG2GNB1AKT1MAPTAPP | |
| SCHEMBL3896104 | 0.80 | ELANE (0.38) | GNG2GNB1AKT1MAPTALDH1A1 | |
| SCHEMBL31423808 | 0.80 | GNG2 (0.49) | GNG2GNB1AKT1MAPTSNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1592825-B1 | MIXTURE OF OLIGOMERIC PHENAZINIUM COMPOUNDS AND ACID BATH FOR ELECTROLYTICALLY DEPOSITING A COPPER DEPOSIT | ATOTECH DEUTSCHLAND GMBH (DE) | 2009-03-25 | — | — | EP | claimed |
| EP-1651801-B1 | AQUEOUS, ACIDIC SOLUTION AND METHOD FOR ELECTROLYTICALLY DEPOSITING COPPER COATINGS AS WELL AS USE OF SAID SOLUTION | ATOTECH DEUTSCHLAND GMBH (DE) | 2008-01-23 | — | — | EP | claimed |
| US-20060226021-A1 | Mixture of oligomeric phenazinium compounds and acid bath for electrolytically depositing a copper deposit | ATOTECH USA, LLC | 2006-10-12 | — | — | US | claimed |
| US-7872130-B2 | Mixture of oligomeric phenazinium compounds and acid bath for electrolytically depositing a copper deposit | ATOTECH DEUTSCHLAND GMBH (DE) | 2011-01-18 | — | — | US | disclosed |
| US-7872130-B2 | Mixture of oligomeric phenazinium compounds and acid bath for electrolytically depositing a copper deposit | ATOTECH DEUTSCHLAND GMBH (DE) | 2011-01-18 | — | — | US | disclosed |
| US-7872130-B2 | Mixture of oligomeric phenazinium compounds and acid bath for electrolytically depositing a copper deposit | ATOTECH DEUTSCHLAND GMBH (DE) | 2011-01-18 | — | — | US | disclosed |
| EP-1592825-B1 | MIXTURE OF OLIGOMERIC PHENAZINIUM COMPOUNDS AND ACID BATH FOR ELECTROLYTICALLY DEPOSITING A COPPER DEPOSIT | ATOTECH DEUTSCHLAND GMBH (DE) | 2009-03-25 | — | — | EP | disclosed |
| EP-1592825-B1 | MIXTURE OF OLIGOMERIC PHENAZINIUM COMPOUNDS AND ACID BATH FOR ELECTROLYTICALLY DEPOSITING A COPPER DEPOSIT | ATOTECH DEUTSCHLAND GMBH (DE) | 2009-03-25 | — | — | EP | disclosed |
| US-20060226021-A1 | Mixture of oligomeric phenazinium compounds and acid bath for electrolytically depositing a copper deposit | ATOTECH USA, LLC | 2006-10-12 | — | — | US | disclosed |
| EP-1592825-A1 | MIXTURE OF OLIGOMERIC PHENAZINIUM COMPOUNDS AND ACID BATH FOR ELECTROLYTICALLY DEPOSITING A COPPER DEPOSIT | ATOTECH Deutschland GmbH (DE) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004057061-A1 | MIXTURE OF OLIGOMERIC PHENAZINIUM COMPOUNDS AND ACID BATH FOR ELECTROLYTICALLY DEPOSITING A COPPER DEPOSIT | ATOTECH DEUTSCHLAND GMBH (DE) | 2004-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060226021-A1 | Mixture of oligomeric phenazinium compounds and acid bath for electrolytically depositing a copper deposit | PICALM, ATP1A2, RAB5IF | GNG2 2783/4885GNB1 2564/4885AKT1 3628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.